81592-99-6

Basic information

• Product Name: 5-carbaMoyl-2-Methoxybenzene-1-sulfonyl chloride
• Synonyms: 5-carbaMoyl-2-Methoxybenzene-1-sulfonyl chloride;5-Carbamoyl-2-methoxybenzenesulfonyl chloride
• CAS NO: 81592-99-6
• Molecular Formula: C₈H₈ClNO₄S
• Molecular Weight: 249.67142
• Mol File: 81592-99-6.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-carbaMoyl-2-Methoxybenzene-1-sulfonyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 5-carbaMoyl-2-Methoxybenzene-1-sulfonyl chloride(81592-99-6)
• EPA Substance Registry System: 5-carbaMoyl-2-Methoxybenzene-1-sulfonyl chloride(81592-99-6)

Safety Data

• Hazardous Substances Data: 81592-99-6(Hazardous Substances Data)

Upstream product

• 3424-93-9 4-methoxyphenylacetamide 
• 7790-94-5 chlorosulfonic acid 

Downstream Products

• 409359-25-7 5-cyano-2-methoxybenzenesulfonyl chloride 
• 38500-12-8 4-methoxy-3-sulfamoyl-benzoic acid amide 
• 409359-55-3 3-[[2-(2-tert-Butylsulfamoyl-4-isopropylphenyl)ethyl]-sulfamoyl]-4-methoxybenzamide 
• 500303-74-2 5-cyano-N-[2-(4-isopropyl-2-methanesulfonylaminophenyl)-ethyl]-2-methoxybenzenesulfonamide 

Relevant articles and documents

Design of Benzoxathiazin-3-one 1,1-Dioxides as a New Class of Irreversible Serine Hydrolase Inhibitors: Discovery of a Uniquely Selective PNPLA4 Inhibitor

The design and examination of 4,1,2-benzoxathiazin-3-one 1,1-dioxides as candidate serine hydrolase inhibitors are disclosed, and represent the synthesis and study of a previously unexplored heterocycle. This new class of activated cyclic carbamates provi

NOVEL CRYSTALS OF 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE

The present invention provides a novel crystalline form of n-butyl [4-[2-[2-hydroxy-5-(N-hydroxycarbamimidoyl) benzenesulfonylamino]ethyl]-2'-methanesulfonyl-3-yloxy] acetate hydrochloride, pharmaceutical compositions containing the same and their uses, which exhibits excellent inhibitory activities against activated blood coagulation factor X, and is useful for the treatment or prevention of a tromboembolic disease.

5-AMIDINO-2-HYDROXYBENZENESULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES FOR THEIR PREPARATION

The present invention relates to a 5-amidino-2-hydroxybenzenesulfonamide derivative represented by the general formula: wherein R1 is a hydrogen atom or an optionally substituted lower alkyl group; R2 is a di(lower alkyl)amino group,